Disease grouping | % HALY loss (Table 2) [A] | Relative harm of ENDS use vs smoking (Table 3 plus adjusted for acrolein from other sources) [B] | Relative harm in terms of HALY loss (i.e., [A] x [B]) |
---|---|---|---|
Chronic obstructive pulmonary disease (COPD) | 48.9% | 27.6%* | 13.5% |
Cancers (12 types) | 28.3% | 41.8% | 11.8% |
Cardiovascular disease | 22.4% | 34.7%* | 7.8% |
Lower respiratory tract infection | 0.4% | 27.6%* (as per COPD**) | 0.1% |
Total | 100% | 33.2% |